-
Dongchen Pharmaceutical Microcrystalline Cellulose is activated!
Time of Update: 2021-12-24
Activate it!
Activate it!
Dongchen Pharmaceutical’s microcrystalline cellulose is activated!
-
The second batch of the 2021 national drug standard improvement project catalog was announced, containing 9 types of pharmaceutical excipients and 2 general testing methods for pharmaceutical packaging materials
Time of Update: 2021-12-24
Drafting of Guidelines for Biological Evaluation and Test Selection of Pharmaceutical Packaging Materials Research purposes research content Drafting of the Method for Determination of Aromatic Primary Amine Extraction in Pharmaceutical Packaging Materials Research purposes research content In order to ensure the smooth progress of the national drug standard improvement work in 2021, the National Pharmacopoeia Commission has made requirements on issues such as subject management .
-
The CRO industry has entered an explosive period, and pharmaceutical equipment companies have also seized the opportunity to actively deploy
Time of Update: 2021-12-24
The company's development of a characteristic CRO business that combines pharmaceutical equipment and technology can further improve the technical level of the business, and at the same time, it can establish differentiated business advantages, establish unique market competitiveness, and build an industrial ecology .
-
Sanofi Metadragon receives new indication in China for the treatment of sinus rhythm with a history of atrial fibrillation
Time of Update: 2021-12-24
According to the press release, Maidarone is the only antiarrhythmic drug that has been proven to significantly reduce the risk of hospitalization or all-cause death in patients with atrial fibrillation, providing a long-term effective and safer treatment option for patients with atrial fibrillation .
-
Blockbuster IMCD China acquires Dike to accelerate the growth of the personal care market
Time of Update: 2021-12-24
Rotterdam, the Netherlands (December 6, 2021) -IMCD NV ("IMCD" or "Company") , the world's leading distributor of specialty chemicals and ingredients, today announced that IMCD China has signed an agreement to acquire Shanghai Dike Fine Chemical Co.
-
The State Food and Drug Administration released the 49th batch of generic drug reference preparation catalog
Time of Update: 2021-12-24
On December 8, the State Food and Drug Administration issued an announcement stating that the 49th batch of generic drug reference preparations catalogue was now released after the review and dete
-
Sampling inspections continue to tighten, and a number of pharmaceutical companies have been fined
Time of Update: 2021-12-24
was ordered to make corrections, warned, and fined by the Jiangxi Provincial Food and Drug Administration only in June this year for producing and selling inferior medicines .
-
Good news!
Time of Update: 2021-12-24
On December 22, it was reported that Shenzhen Weijiejun Biotechnology Co. , Ltd. (hereinafter referred to as "Unknownjun"), an AI pharmaceutical company focused on intestinal microecological treatmen
-
Janssen's IL-12/IL-23 inhibitor submits a new application to the FDA for the treatment of psoriatic arthritis in children
Time of Update: 2021-12-11
Recently, Janssen, a subsidiary of Johnson & Johnson, announced that it has submitted its IL-12/IL-23 inhibitor Stelara (ustekinumab) supplementary biologics license application (sBLA) to the US FDA for the treatment of 5 Children with juvenile psoriatic arthritis (jPsA) over the age of years .
-
The State Food and Drug Administration announces the acceptance of 2 types of traditional Chinese medicines
Time of Update: 2021-12-11
On October 8, the State Food and Drug Administration released information on the acceptance of protection of traditional Chinese medicine varieties.
and Phlegm Heat from Shanghai Kaibao Pharmaceutical Co.
Qing injection, the application items are all renewal .
-
Subcutaneous injection!
Time of Update: 2021-12-11
Previously, daratumomab subcutaneous injection has been approved by the FDA in the United States for the treatment of multiple myeloma, light chain (AL) amyloidosis and other indications .
com/us-food-and-drug-administration-approves-darzalex-fasprotm-daratumumab-and-hyaluronidase-fihj-new[3] Genmab Announces Positive Topline Results in Phase III ANDROMEDA Study of Daratumumab in Light-chain (AL) Amyloidosis.
-
Novavax and SII are authorized for emergency use of vaccines in Indonesia
Time of Update: 2021-12-09
(NASDAQ: NVAX), a biotechnology company dedicated to the development and commercialization of next-generation vaccines for severe infectious diseases, and Serum Institute of India Private Limited (SII), the world’s largest vaccine manufacturer, announced today that the National Agency for Medicines and Food Control of the Republic of Indonesia (Badan Peng was Obat dan Makanan (Badan POM)) has granted Novavax the use of Matrix-M™ adjuvant Emergency Use Authorization (EUA) for the recombinant nanoparticle protein new coronary pneumonia vaccine .
-
AMX0035 has submitted a new drug application to the FDA for the treatment of amyotrophic lateral sclerosis
Time of Update: 2021-12-09
A few days ago, Amylyx Pharmaceuticals announced that it has submitted a New Drug Application (NDA) for AMX0035 to the US FDA for the treatment of amyotrophic lateral sclerosis (ALS) .
Reference materials:[1] Amylyx Pharmaceuticals Submits New Drug Application (NDA) for AMX0035 for the Treatment of ALS.
-
FCN-342 Tablets, a subsidiary of Fosun Pharma Holding Group, Obtained Drug Clinical Trial Approval
Time of Update: 2021-12-09
The new drug is a URAT1 inhibitor independently developed by the company and is intended to be mainly used for the treatment of gout and hyperuricemia .
As of September 2021, the Group has invested approximately RMB 18 million in R&D for this new drug at this stage (unaudited) .
-
Delisting of well-known pharmaceutical companies!
Time of Update: 2021-12-09
com, in recent years, the terminal throat Chinese patent medicine market in physical pharmacies in cities in China has hovered at the 5 billion mark, with Yangzijiang Pharmaceutical, Guilin Sanjin, and Golden Throat ranking the top three .
-
TOP10 ophthalmic drugs exposed!
Time of Update: 2021-12-09
According to the latest data from Mi Nei. com, the sales of terminal ophthalmic drugs in public medical institutions in China in 2021H1 exceeded 5 billion yuan, a year-on-year increase of 29.
-
First-line treatment of NSCLC!
Time of Update: 2021-12-09
ArticleMedicine GuanlanOn November 1, Allis Pharmaceuticals announced that its third-generation EGFR-TKI drug Ivesa (Vometinib mesylate) is the first-line treatment for locally advanced or metastatic non-small cell lung cancer (NSCLC) with sensitive EGFR mutations.
-
Tianyan Pharmaceutical will announce the preclinical data of two transformative antibody projects at the ASH annual meeting
Time of Update: 2021-12-09
Suzhou, China and San Diego, USA November 5, 2021/PRNewswire/ - Tianyan Pharmaceutical (hereinafter referred to as the "Company" or "Tianyan") (NASDAQ: ADAG) is a platform-driven clinic A stage biopharmaceutical company dedicated to discovering and developing new cancer immunotherapies based on original antibodies .
-
Soaring 20 times!
Time of Update: 2021-12-09
According to CCTV Financial News, Carzodopa sustained-release tablets have been out of stock on the market recently, and many patients have posted in "Parkinson's Bar" to buy drugs from their patients in order to seek medicine .
-
Soaring 973%!
Time of Update: 2021-12-09
Figure 1: The situation of products declared by Sichuan Guowei for the production of pharmaceuticalsSource: CED official websiteIn recent years, irritable bowel syndrome (IBS) is considered to be a global functional disease with the highest incidence.
